For Research Use Only — in-vitro and animal research applications. Not for human consumption or clinical use.
Comparison

NAD+ vs 5-Amino-1MQ: Two Approaches to NAD Pool Research

Published 2026-06-11 · 6 min read

NAD+ and 5-amino-1MQ both raise NAD+ availability in published research models, but they do so through entirely different mechanisms. NAD+ supplies the cofactor directly. 5-Amino-1MQ inhibits an enzyme — nicotinamide N-methyltransferase (NNMT) — that otherwise depletes the nicotinamide pool used in NAD+ salvage. The two compounds are sometimes treated as alternatives in NAD-pool research, but their effects on the rest of methyl-donor biology are meaningfully different.

At a glance

NAD+5-amino-1MQ
Compound classEndogenous redox cofactor (dinucleotide)Small-molecule NNMT inhibitor (5-amino-1-methylquinolinium)
Mechanism classDirect supply of the NAD+ poolInhibits nicotinamide N-methyltransferase (NNMT); spares nicotinamide for NAD+ salvage
Effect on the NAD+ poolIncreases NAD+ availability directlyIncreases NAD+ availability indirectly via reduced nicotinamide methylation
Effect on SAMNo direct effectSpares S-adenosylmethionine (SAM) — methyl donor pool also rises
Primary research focusSirtuin biology, DNA repair, mitochondrial respiration, longevity researchAdipocyte biology, NNMT-overexpressing tissues, metabolic research
Most-cited research modelsSirtuin activity assays, NAD+/NADH ratio, mitochondrial respiration studiesWhite adipose tissue models, NNMT activity assays, methyl-donor sparing studies
Typical research vial size500 mg / 1000 mgPer product page

NAD+ — direct cofactor supply

NAD+ is a central redox cofactor and a substrate for the sirtuin family, PARPs, and CD38. The most-studied consequence of raising NAD+ in research models is increased sirtuin activity and improved mitochondrial respiration. In comparative work, NAD+ supplementation is the direct arm — the cofactor is added, downstream NAD+-consuming enzymes have more substrate, and the readouts (sirtuin activity, NAD+/NADH ratio, OCR) follow.

For deeper background, see the NAD+ Reference Guide.

5-Amino-1MQ — NNMT inhibition

5-Amino-1MQ blocks NNMT, an enzyme that uses S-adenosylmethionine (SAM) to methylate nicotinamide into 1-methyl-nicotinamide. The methylated product is a metabolic dead-end — it cannot be salvaged back into NAD+. By inhibiting NNMT, 5-amino-1MQ has two effects: nicotinamide stays available for the NAD+ salvage pathway, and SAM is spared because it is no longer consumed by nicotinamide methylation. The result is a coordinated rise in both the NAD+ pool and the methyl-donor pool, which appears across the research literature as a distinctive signature in NNMT-overexpressing tissues — especially white adipose tissue.

For deeper background, see the 5-Amino-1MQ Reference Guide.

Complementary, not substitutable

The two compounds are sometimes treated as interchangeable tools for raising NAD+, but the methyl-donor arm of 5-amino-1MQ is distinctive — NAD+ supplementation does not produce the same effect on SAM. In research designs that care about the methylation landscape, the two are complementary rather than substitutable: NAD+ supplies the cofactor; 5-amino-1MQ shifts the balance of nicotinamide clearance versus methyl-donor sparing.

In comparative work, running both arms — alone and in combination — lets the design attribute observed effects to cofactor supply, methyl-donor sparing, or the intersection of the two.

Tissue specificity matters

NNMT is highly expressed in white adipose tissue, liver, and certain cancer cell lines. In tissues with low NNMT expression, 5-amino-1MQ has little to do — its effect is proportional to the local NNMT activity it is blocking. NAD+ supplementation, by contrast, raises the cofactor pool broadly because most tissues use NAD+. The choice between the two compounds therefore depends partly on the tissue question being asked.

Choosing between them

  • Sirtuin biology, mitochondrial respiration, broad NAD+ pool research: NAD+ is the direct tool.
  • NNMT-overexpressing tissue research (adipose, liver): 5-amino-1MQ is the relevant tool because the mechanism depends on local NNMT activity.
  • Methyl-donor sparing research: 5-amino-1MQ is the only one of the two that shifts the SAM pool.
  • Mechanism dissection: run both arms in parallel — and in combination — to dissociate cofactor supply from NNMT inhibition.

Lab handling

Both compounds are lyophilized and stable at −20°C. Both reconstitute cleanly in bacteriostatic water. For step-by-step procedure that applies here, see How to Reconstitute BPC-157. For pre-computed dilution math at the vial sizes used in this research, see the Peptide Dilution Table.

For Research Use Only. Information presented for laboratory and research applications. Not medical advice and not a substitute for qualified scientific judgment.